Acute Mesenteric Ischemia Clinical Trial
— AMESIOfficial title:
Incidence, Diagnosis, Management and Outcome of Acute Mesenteric Ischaemia: a Prospective, Multicentre Observational Study
NCT number | NCT05218863 |
Other study ID # | AMESI Study |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 6, 2022 |
Est. completion date | April 5, 2023 |
Verified date | May 2023 |
Source | University of Tartu |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a prospective, multicentre observational study screening all adult patients admitted to a participating hospital over a 6-month study period (may be adjusted to 4-8 months according to recruitment) and including all patients with suspicion of or confirmed acute mesenteric ischaemia (AMI). Only admission data and hospital mortality outcome will be collected for patients in whom suspicion of AMI is not confirmed. For patients with confirmed AMI full data collection regarding diagnostics, management and long-term outcome is required. Investigators aim to recruit 40-50 sites with expected median of 10-20 patients with confirmed AMI per site during the study period (naturally depending on the size of the hospital). The start of the study is planned for Spring 2022. The aim of the study is to identify the incidence of AMI and its different forms in adult hospitalized patients, and to describe patient characteristics (demographic, clinical and laboratory) at baseline, applied diagnostics and management, as well as outcomes in patients with AMI. An additional aim is to compare the baseline characteristics and outcomes of patients with confirmed AMI to those of patients with suspected AMI in whom the diagnosis was not confirmed.
Status | Completed |
Enrollment | 709 |
Est. completion date | April 5, 2023 |
Est. primary completion date | April 5, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: All patients with suspected AMI Exclusion Criteria: Age <18 years Consent declined by patient or next of kin Chronic mesenteric ischaemia without an acute event |
Country | Name | City | State |
---|---|---|---|
Estonia | North Estonian Regional Hospital | Tallinn | |
Estonia | Tartu University Hospital | Tartu | |
Switzerland | Kantonsspital Luzern | Luzern |
Lead Sponsor | Collaborator |
---|---|
University of Tartu |
Estonia, Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of AMI | Incidence of AMI in hospitalized adult patients in acute care hospitals | 6 months | |
Secondary | 30 days survival of AMI | survival of patients with confirmed AMI | 30 days after admission/suspicion of AMI/study inclusion | |
Secondary | Proportion of different forms of AMI | Proportion of each form of AMI from all AMI cases | 6 months | |
Secondary | Time to diagnosis | Time from symptoms to diagnosis | through study completion, study duration 6 months | |
Secondary | Time to treatment | Time from diagnosis to treatment | through study completion, study duration 6 months | |
Secondary | Treatment | Surgery, endovascular intervention or palliation | through study completion, study duration 6 months | |
Secondary | 1 year survival | Survival of patients with AMI 1 year after diagnosis | 1 year | |
Secondary | Quality of life score | EQ-5D-5L (EuroQoL - European Quality of Life ), 5-25 points, the lower score means better outcome | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05194527 -
The Detrimental Course of Acute Intestinal Ischemia
|
||
Not yet recruiting |
NCT06387147 -
ORal Antibiotics In Acute Mesenteric Ischemia
|
Phase 3 | |
Completed |
NCT04867499 -
Epidemiology of Acute Mesenteric Ischemia
|
||
Not yet recruiting |
NCT06212921 -
Biomarkers in Prediction of AMI
|
N/A | |
Recruiting |
NCT03518099 -
Searching Biomarkers of Acute Intestinal Ischemic Injuries
|
N/A | |
Not yet recruiting |
NCT06428240 -
Acute Mesenteric Ischemia, Reality in Catalonia
|
||
Active, not recruiting |
NCT06365827 -
Perioperatively Assessed Biomarker I-FABP Level for Prediction of Acute Mesenteric Ischemia and Its Correlation With Acute Kidney Injury, Followed by Extracorporeal Circulation (aMIKI)
|
||
Recruiting |
NCT06445660 -
The Feasibility of a Radiological Score Based on CT Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia
|
||
Completed |
NCT05706012 -
Antithrombotic Management of Acute Mesenteric Ischaemia
|
||
Not yet recruiting |
NCT06310395 -
Analysis of the Acute Mesenteric Ischemia in a Single Institution Over 10 Years
|
||
Completed |
NCT05665946 -
Acute Intestinal Necrosis- the Preoperative Diagnostic Approach
|
||
Recruiting |
NCT01788904 -
Plasma i-FABP as Predictor for Irreversible Bowel Ischemia
|
N/A | |
Recruiting |
NCT02772913 -
Mesenteric Ischemia in the Emergency Department: a Retrospective Multicenter Study
|
N/A |